Evidence map›Paper›PMID 40140887›Full record

ArticleBMC medicine2025

Diagnosis of celiac disease on a gluten-free diet: a multicenter prospective quasi-experimental clinical study.

Sara Gómez-Aguililla, Sergio Farrais, Natalia López-Palacios, Beatriz Arau, Carla Senosiain, María Corzo, Nora Fernandez-Jimenez, Ángela Ruiz-Carnicer, Fernando Fernández-Bañares, Bárbara P González-García and 10 more

Abstract readMulticenter Study
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sara Gómez-Aguililla *Laboratorio de Investigación en Genética de enfermedades complejas, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, 28040, Spain. gmz.sra@gmail.com.ORCID http://orcid.org/0000-0002-7525-1408
Sergio Farrais *Servicio de Aparato Digestivo, Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, 28040, Spain.
Natalia López-PalaciosServicio de Aparato Digestivo, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, 28040, Spain.
Beatriz ArauDepartment of Gastroenterology, Hospital Universitari Mutua Terrassa, Terrassa (Barcelona), Spain.
Carla SenosiainServicio de Aparato Digestivo, Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain.
María CorzoLaboratorio de Investigación en Genética de enfermedades complejas, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, 28040, Spain.
Nora Fernandez-JimenezDepartment of Genetics, Physical Anthropology and Animal Physiology, Biobizkaia Health Research Institute, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain.
Ángela Ruiz-CarnicerDepartamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Seville, 41012, Spain.
Fernando Fernández-BañaresDepartment of Gastroenterology, Hospital Universitari Mutua Terrassa, Terrassa (Barcelona), Spain.
Bárbara P González-GarcíaDepartment of Genetics, Physical Anthropology and Animal Physiology, Biobizkaia Health Research Institute, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain.
Eva TristánDepartment of Gastroenterology, Hospital Universitari Mutua Terrassa, Terrassa (Barcelona), Spain.
Ana Montero-CalleFunctional Proteomics Unit, Chronic Disease Programme, Instituto de Salud Carlos III, Majadahonda, Madrid, 28220, Spain.
María Garranzo-AsensioFunctional Proteomics Unit, Chronic Disease Programme, Instituto de Salud Carlos III, Majadahonda, Madrid, 28220, Spain.
Isabel CasadoServicio de Anatomía Patológica, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, 28040, Spain.
Mar PujalsDepartment of Gastroenterology, Hospital Universitari Mutua Terrassa, Terrassa (Barcelona), Spain.
Juana María HernándezDepartment of Gastroenterology, Hospital Universitari Mutua Terrassa, Terrassa (Barcelona), Spain.
Jorge Infante-MenéndezLaboratorio de Investigación en Genética de enfermedades complejas, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, 28040, Spain.
Garbiñe RoyServicio de Inmunología, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, 28034, Spain.
Carolina SousaDepartamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad de Sevilla, Seville, 41012, Spain.
Concepción NúñezLaboratorio de Investigación en Genética de enfermedades complejas, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, 28040, Spain. conchita.npardo@gmail.com.ORCID http://orcid.org/0000-0002-9489-1603

Funding

Agencia Estatal de Investigación and RETOS funds RTC2019-006806-1Departament de Salut, Generalitat de Catalunya (Program for the Incorporation of Support Staff into Research Groups) SLT028/23/000194Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) PI21/00271Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) PI21/01491Ministerio de Ciencia e Innovación DI-17-096274Osasun Saila, Eusko Jaurlaritzako 2019/111085
6 · The paper itself

Abstract

backgroundDiagnosing celiac disease (CD) in individuals adhering to a gluten-free diet (GFD) presents significant challenges. Current guidelines recommend a gluten challenge (GC) lasting at least 6-8 weeks, which has several limitations. Our aim was to compare four approaches previously proposed for diagnosing CD on a GFD: IL-2 serum levels, gut-homing CD8

methodsWe conducted a multicenter prospective quasi-experimental clinical study. Two subsets of individuals were considered: (1) 20 patients with CD previously diagnosed and 15 non-CD controls, to evaluate the first aim; (2) 41 individuals with uncertain diagnosis who were on a GFD and required GC following current clinical guidelines, to assess the second aim. All participants underwent a 3-day GC (10 g gluten/day).

resultsAmong CD patients and non-CD controls, the sensitivity and specificity of IL-2, gut-homing CD8

conclusionsThe percentage of TCRγδ

Indexed as

Celiac DiseaseDiet, Gluten-FreeAdultAgedCD8-Positive T-LymphocytesFemaleGlutensHumansInterleukin-2Intraepithelial LymphocytesMaleMiddle AgedProspective StudiesSensitivity and SpecificityYoung AdultGlutensInterleukin-2CD8+ T cellsCeliac diseaseGluten challengeGluten-free diet

Identifiers

PMID40140887
PMCPMC11948932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.